The cannabis industry is budding as some sales projections are expected to exceed $1.7 billion by 2022. Licenses to sell medical marijuana in Florida repeatedly fetch a price tag of over $40 million. The catch: Florida tightly regulates the amount of licenses it issues for the sale of medical marijuana. Therefore, companies that desire to enter the market resort to purchasing the license from an existing license holder. However, that may soon change.

On Oct. 16, the Florida Supreme Court accepted review of a case that involves a key component of Florida’s regulatory structure for medical marijuana licenses. Gov. Ron DeSantis’ office asked the Supreme Court to take up the case, which would address the frameworks of Florida’s vertical integration requirement for cannabis companies.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]